Zhejiang Doer Biologics Co., Ltd.

This study tested a new injectable drug called DR10624 to see if it could safely lower very high levels of triglycerides, a type of fat in the blood. It involved 79 adults with severe hypertriglyceridemia, who received either the drug or a placebo (dummy shot) for 12 weeks. The m…